TMPRSS2 and prostate carcinoma: VCaP cells are derived from a metastatic lesion to a lumbar vertebrae of a Caucasian male with hormone refractory prostate cancer; VCaP is a TMPRSS2-ERG fusion-positive prostate cancer cell line, expressing high levels of the androgen receptor splice variant AR-V7 [22].